IMGENEX India Pvt Ltd. the only biotech company in Orissa and one of its kinds in Eastern India. IMGENEX India started in Oct as an outsourcing branch of IMGENEX Corporation, San Diego, USA. The classical
pathway for activation of NF-kB, a key transcriptional regulator of the immune
system, is controlled by the IKK complex. Activated IKK phosphorylates IkB
which is ubiquitinated and rapidly degraded, allowing NF-kB to translocate from
the cytoplasm to the nucleus where it activates gene
transcription. However, the mechanisms regarding IKK activation have been
elusive.
Now CARMA1, Bcl-10,
and MALT1 are helping to fill in the blanks of IKK activation. These
proteins are downstream of the T cell receptor (TCR) and upstream of the IKK
complex (Fig. 1). Antigen-TCR signaling in the adaptive immune system leads to
PKC-q activation and formation of an oligomerization-ubiquitination
(Ub)-phosphorylation (P) pathway leading to activated IKK. Oligomerization-Ub-P
pathways have also been found to mediate NF-kB activation through TLR
(Toll-like receptor) signaling; suggesting these emerging IKK activation
pathways may play key roles in regulating both adaptive and innate immunity.